Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Learn About the Memorial Sloan-Kettering Lung Study

Summary

The Memorial Sloan-Kettering Lung Study (MEM) was a randomized screening trial designed to test if lung cancer mortality rates could be reduced through the addition of regular cytomorphological screening of sputum to an annual chest x-ray screening regimen. The reported lung cancer mortality rates were similar between the two arms indicating the additional cytological screening did not result in a benefit. The follow-up of participants was of limited duration.

Study Years: 1971-1983

  • Enrollment: June 10, 1974 to January 10, 1978
  • Screening was phased out, starting in January 1982 and ending October 31, 1982.
  • Participants were screened for five to eight years, depending on date of enrollment.

Randomized trial with two arms:

  • Control: Single-Screen: Annual Chest X-Ray Only
  • Intervention: Dual-Screen: Annual Chest X-Ray and four-monthly sputum cytology

Study Eligibility:

  • Ages Eligible for Study: 45+ Years
  • Sexes Eligible for Study: Male
  • Smoked at least one pack of cigarettes per day (or this much within one year of enrollment)
  • No history of respiratory tract cancer